In today's intricate world of biotechnology, innovation often emerges from the transformation of existing knowledge and assets. Faisal Zain, a healthcare expert with deep roots in medical technology, joins us to discuss the significant establishment and aspirations of Antares Therapeutics
In the ever-evolving field of oncology, Bristol Myers Squibb has made waves with its strategic expansion into radiopharmaceuticals for prostate cancer. Leading this charge is the promising compound, OncoACP3, developed in collaboration with Philochem. Here to talk about these exciting developments
In recent years, public health experts have increasingly highlighted an unexpected consequence of climate change: the significant rise in allergies worldwide. As global temperatures climb and pollutants proliferate, the frequency and severity of allergic reactions have become an urgent issue
In a substantial shift towards more inclusive health policy, Texas has taken significant strides to expand access to medical cannabis under House Bill 46. This legislation marks a notable transition for the state's medical cannabis framework, broadening both the scope of eligibility and the
The advent of Yeztugo, a twice-yearly injectable medication for HIV prevention, is sparking significant interest in the medical community. Approved by the U.S. Food and Drug Administration (FDA), this breakthrough drug offers a new option for adults and adolescents weighing at least 77 pounds,
Does innovation in genetic treatments outweigh potential fatal risks for patients? This crucial question arises following concerns about Elevidys, a gene therapy for Duchenne muscular dystrophy (DMD). Recent fatalities have stirred conversations around its safety for non-ambulatory patients—these a
